← Open Payments lookup

JAMES MCCORMACK: Open Payments

NPI 1487102596 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,087 in 50 payments from 10 companies in 2025. Trend: 2023 $2,179 · 2024 $719 · 2025 $1,087

Food & beverage: $1,087
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$258
Vanda Pharmaceuticals Inc.10$202
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$194
Alkermes, Inc.6$127
Axsome Therapeutics, Inc.4$101
Lundbeck LLC5$81
ABBVIE INC.4$60
Teva Pharmaceuticals USA, Inc.1$30
Janssen Pharmaceuticals, Inc1$17
Supernus Pharmaceuticals, Inc.1$16

Products named: CAPLYTA, REXULTI, FANAPT, ARISTADA, ABILIFY MAINTENA, Auvelity, HETLIOZ, VRAYLAR.

Industry payments across AR — which companies pay providers there.